Osborne Clarke advised Creo Europe on the deal.Micro-Tech Nanjing, a Chinese producer of minimally invasive medical devices, acquired a controlling stake (51%) of Creo Medical from…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
